MicroRNA-based therapy in cardiology

Herz

Volumn 39, Issue 2, 2014, Pages 194-200

  Fiedler, J ^a   Batkai, S ^a   Thum, T ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cardiac hypertrophy; Heart failure; MicroRNA; MiR therapies; Review

Indexed keywords

ADENOVIRUS VECTOR; ANTAGOMIR; MESSENGER RNA; MICRORNA; MICRORNA 1; MICRORNA 101; MICRORNA 126; MICRORNA 132; MICRORNA 133; MICRORNA 133A; MICRORNA 133B; MICRORNA 16; MICRORNA 195; MICRORNA 199B; MICRORNA 208B; MICRORNA 21; MICRORNA 212; MICRORNA 22; MICRORNA 23B; MICRORNA 24; MICRORNA 25; MICRORNA 27A; MICRORNA 29; MICRORNA 29A; MICRORNA 29B; MICRORNA 30; MICRORNA 34A; MICRORNA 92A; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CARDIOLOGY; DIFFERENTIAL DIAGNOSIS; DRUG TARGETING; FIBROGENESIS; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENE THERAPY; HEART FAILURE; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PATHOGENESIS; UNSTABLE ANGINA PECTORIS; VIRAL GENE THERAPY; EVIDENCE BASED MEDICINE; GENETICS; HEART DISEASES; PERSONALIZED MEDICINE; PROCEDURES; TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; GENETIC THERAPY; HEART DISEASES; HUMANS; INDIVIDUALIZED MEDICINE; MICRORNAS; TREATMENT OUTCOME;

EID: 84899407019     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-013-4047-0     Document Type: Article

References (41)

1. Hill JA, Olson EN (2008) Cardiac plasticity. N Engl J Med 358:1370-1380
2. Cohn JN, Ferrari R, Sharpe N (2000) Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35:569-582
3. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854
4. Wightman B, Ha I, Ruvkun G (1993) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75:855-862
5. Lewis BP, Shih IH, Jones-Rhoades MW et al (2003) Prediction of mammalian microRNA targets. Cell 115:787-798
6. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20
7. Rooij E van, Sutherland LB, Liu N et al (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 103:18255-18260
8. Izumo S, Nadal-Ginard B, Mahdavi V (1988) Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci U S A 85:339-343
9. Thum T, Galuppo P, Wolf C et al (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116:258-267
10. Khan R, Sheppard R (2006) Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 118:10-24
11. Thum T, Gross C, Fiedler J et al (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456:980-984
12. Rooij E van, Sutherland LB, Thatcher JE et al (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105:13027-13032
13. Duisters RF, Tijsen AJ, Schroen B et al (2009) miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 104:170-178 (6p following 178)
14. Abonnenc M, Nabeebaccus AA, Mayr U et al (2013) Extracellular Matrix Secretion by Cardiac Fibroblasts: Role of MicroRNA-29b and MicroRNA-30c. Circ Res 113:1138-1147
15. Zhao Y, Ransom JF, Li A et al (2007) Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129:303-317
16. Costa Martins PA da, Bourajjaj M, Gladka M et al (2008) Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 118:1567-1576
17. Rao PK, Toyama Y, Chiang HR et al (2009) Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res 105:585-594
18. Zampetaki A, Willeit P, Tilling L et al (2012) Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol 60:290-299
19. Widera C, Gupta SK, Lorenzen JM et al (2011) Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 51:872-875
20. Krutzfeldt J, Rajewsky N, Braich R et al (2005) Silencing of microRNAs in vivo with ?antagomirs?. Nature 438:685-689
21. Lennox KA, Behlke MA (2011) Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther 18:1111-1120
22. Rooij E van (2011) The art of microRNA research. Circ Res 108:219-234
23. Thum T (2012) MicroRNA therapeutics in cardiovascular medicine. EMBO Mol Med 4:3-14
24. Liu G, Friggeri A, Yang Y et al (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207:1589-1597
25. Chau BN, Xin C, Hartner J et al (2012) MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med 4:121ra18
26. Pan Z, Sun X, Shan H et al (2012) MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-beta1 pathway. Circulation 126:840-850
27. Ucar A, Gupta SK, Fiedler J et al (2012) The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun 3:1078
28. Costa Martins PA da, Salic K, Gladka MM et al (2010) MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol 12:1220-1227
29. Dirkx E, Gladka MM, Philippen LE et al (2013) Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. Nat Cell Biol 15:1282-1293
30. Bernardo BC, Gao XM, Winbanks CE et al (2012) Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci U S A 109:17615-17620
31. Boon RA, Iekushi K, Lechner S et al (2013) MicroRNA-34a regulates cardiac ageing and function. Nature 495:107-110
32. Fish JE, Santoro MM, Morton SU et al (2008) miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15:272-284
33. Solingen C van, Seghers L, Bijkerk R et al (2009) Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med 13:1577-1585
34. Bonauer A, Carmona G, Iwasaki M (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324:1710-1713
35. Fiedler J, Jazbutyte V, Kirchmaier BC et al (2011) MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 124:720-730
36. Meloni M, Marchetti M, Garner K et al (2013) Local inhibition of microRNA-24 improves reparative angiogenesis and left ventricle remodeling and function in mice with myocardial infarction. Mol Ther 21:1390-1402
37. Zhou Q, Anderson C, Zhang H et al (2013) Repression of choroidal neovascularization through actin cytoskeleton pathways by MicroRNA-24. Mol Ther doi:10.1038/mt.2013.243
38. Roncarati R, Anselmi CV, Losi MA et al (2013) Circulating miR-29a, Among other upregulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol doi:10.1016/j.jacc.2013.09.041
39. Devaux Y, Vausort M, McCann GP et al (2013) A panel of 4 microRNAs facilitates the prediction of left ventricular contractility after acute myocardial infarction. PLoS One 8:e70644
40. Halkein J, Tabruyn SP, Ricke-Hoch M et al (2013) MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 123:2143-2154
41. Jaguszewski M, Osipova J, Ghadri JR et al (2013) A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction. Eur Heart J doi:10.1093/eurheartj/eht392